VYNE Therapeutics (VYNE) shares were down 41% in Friday premarket trading as the company's 1-for-50 reverse stock split is expected to become effective, with the shares to begin trading on a post-split basis on Monday.
China SXT Pharmaceuticals (SXTC) stock was down 27% after the company entered into a definitive securities purchase agreement for a registered direct offering of 4.5 million units at $2.00 per unit.
Codexis (CDXS) shares were down 26% after the company priced an underwritten public offering of about 16.7 million common shares at $1.50 per share.
TDH (PETZ) stock was down 19%, reversing the previous session's 13% decline.
Comments